Is a complete FRA/0FY research report available?

No complete published report is available for fra/0FY (FRA/0FY) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/0FY (FRA/0FY)

Frankfurt Stock Exchange: FRA/0FY · EUR

€1.88

-0.02 (-1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/0FY analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	126.7M
Net income (ttm)	-16.5M
EPS (ttm)	-€0.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -16.5M
EPS (ttm): -€0.23
Market cap: 126.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-07-31 02:00 UTC

All FRA/0FY indicators

Market & fundamental data

Available fields

138

Groups with data

Currency

USD

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	15
Employees Change	-20%
Employees Change Percent	-57.14
Enterprise value	EUR 73.4M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 126.7M
Price	EUR 1.88
Price currency	EUR
Sic	2836
Symbol	fra/0FY
Website	https://www.equilliumbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.05%
FCF yield	-12.96%
P/B ratio	2.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -16.5M
Profit Per Employee	EUR -1.1M
ROA	-31.91
Roa5y	-27.29
ROCE	-34.11
ROE	-54.39
Roe5y	-73.15
ROIC	-35.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	447.54%
Cagr3y	41.55%
Cagr5y	-17.16%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 54.7M
Cash	EUR 53.2M
Current Assets	EUR 54M
Current Liabilities	EUR 2.9M
Debt	EUR 600,172
Debt Equity	EUR 0.01
Debt FCF	EUR -0.04
Equity	EUR 51.6M
Liabilities	EUR 3.1M
Long Term Assets	EUR 724,568
Long Term Liabilities	EUR 218,970
Net Cash	EUR 52.6M
Net Cash By Market Cap	EUR 41.51
Net Cash Growth	326.76%
Net Debt Equity	EUR -1.02
Tangible Book Value	EUR 51.6M
Tangible Book Value Per Share	EUR 0.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.62
Net Working Capital	EUR -1.7M
Quick ratio	18.33
Working Capital	EUR 51.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-104.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	446.9%
200-day SMA	1.55
3Y total return	183.68%
50-day SMA	2.32
50-day SMA vs 200-day SMA	50over200
5Y total return	-60.99%
All Time High	23.6
All Time High Change	-91.97%
All Time High Date	2020-07-14
All Time Low	0.25
All Time Low Change	658%
All Time Low Date	2025-06-16
ATR	0.15
Ch YTD	59.51
High	1.9
High52	2.81
High52 Date	2026-06-30
High52ch	-33.27%
Low	1.88
Low52	0.32
Low52 Date	2025-07-31
Low52ch	485.94%
Ma50ch	-18.28%
Price vs 200-day SMA	22.34%
RSI	38.69
RSI Monthly	55.59
RSI Weekly	49.93
Sharpe ratio	1.71x
Sortino ratio	3.82
Total Return	-104.5%
Tr YTD	59.51
Tr1m	-25.39%
Tr1w	-14.64%
Tr3m	10.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -17.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,435,708%
Shares Insiders	10.49%
Shares Institutions	38.35%
Shares Qo Q	4.79%
Shares Yo Y	104.5%
Short Ratio	6.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -18.7M
Adjusted OCF	-18,654,755
Average Volume	0x
Bv Per Share	0.82
CAPEX	EUR -40,763
Ch1m	-25.39
Ch1w	-14.64
Ch1y	446.9
Ch3m	10.17
Ch3y	183.7
Ch5y	-60.99
Ch6m	77.43
Change	-1.06%
Change From Open	-1.32
Close	1.9
Days Gap	0.26
Depreciation Amortization	92,760.2
Earnings Date	2026-08-11
EBIT	EUR -17.7M
EBITDA	EUR -17.6M
EPS	EUR -0.23
F Score	2
FCF	EUR -16.4M
FCF EV Yield	-22.36x
Financing CF	56,965,999
Fiscal Year End	December
Founded	2,017
Investing CF	-30,356
Is Primary Listing	0
Last Report Date	2026-03-31
Ma150	1.74
Ma150ch	8.91%
Ma20	2.28
Ma20ch	-16.81%
Net CF	40,606,986
Next Earnings Date	2026-08-11
Open	1.9
Position In Range	0
Ppne	677,063
Price Date	2026-07-30
Ptbv Ratio	2.46
Relative Volume	1.3x
Share Based Comp	2,281,866
Tr6m	77.43%

FRA/0FY (FRA/0FY)

Coverage state: Market snapshot only — no published research

Generate the first FRA/0FY analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/0FY

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All FRA/0FY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/0FY

Frequently asked questions